Galectin Therapeutics (GALT)'s 30-day implied volatility (IV30) was 83.1% at the close on November 3, 2026, down from 96.1% the day before, against a 52-week range of 58.3% to 185.2%. Its 20-day historical volatility was 76.0%.
Data as of November 3, 2026.